These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4855832)

  • 1. Blocking activity induced by solubilized alloantigens.
    Zighelboim J; Bonavida B; Rao VS; Fahey JL
    J Immunol; 1974 Jan; 112(1):433-5. PubMed ID: 4855832
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens.
    Bonavida B
    J Immunol; 1974 Mar; 112(3):926-34. PubMed ID: 4544178
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of H-2 alloantigens solubilized by the detergent NP-40.
    Schwartz BD; Nathenson SG
    J Immunol; 1971 Nov; 107(5):1363-7. PubMed ID: 5171127
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of antigen density and non-complement fixing antibody on cytolysis by alloantisera.
    Basch RS
    J Immunol; 1974 Aug; 113(2):554-62. PubMed ID: 4846266
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for several cell populations active in antibody dependent cellular cytotoxicity.
    Zighelboim J; Bonavida B; Fahey JL
    J Immunol; 1973 Dec; 111(6):1737-42. PubMed ID: 4750865
    [No Abstract]   [Full Text] [Related]  

  • 7. Subcellular mouse alloantigens: cytotoxic immune responses and specific blocking in vitro.
    Wagner H; Boyle W
    Nat New Biol; 1972 Nov; 240(98):92-4. PubMed ID: 4539049
    [No Abstract]   [Full Text] [Related]  

  • 8. The level and distribution of antibody in syngeneic and allogeneic mated pregnant mice pre-immunized with H-2 alloantigens.
    Taylor GM
    Immunology; 1973 Nov; 25(5):703-92. PubMed ID: 4586737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protein nature of the Thy-1.2 alloantigen as expressed by the murin lymphoblastoid line S-49.1 TB-2-3.
    Kucich UN; Bennett JC; Johnson BJ
    J Immunol; 1975 Sep; 115(3):626-30. PubMed ID: 1151070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic immune cells with specificity for defined soluble antigens. V. Interaction of antibody with the cytotoxic effector cells in immune or non-immune mouse spleen cells.
    Schirrmacher V; Rubin B; Pross H
    J Immunol; 1974 Jun; 112(6):2219-26. PubMed ID: 4856907
    [No Abstract]   [Full Text] [Related]  

  • 11. Generation of non-complement-fixing, blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies.
    Dauphinee MJ; Talal N; Witz IP
    J Immunol; 1974 Sep; 113(3):948-53. PubMed ID: 4413555
    [No Abstract]   [Full Text] [Related]  

  • 12. Preferential induction of serum blocking activity and enhancement of skin allograft by soluble alloantigen.
    Rao VS; Bonavida B; Zighelboim J; Fahey JL
    Transplantation; 1974 Jun; 17(6):568-75. PubMed ID: 4597923
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of the immune response toward allografts in vivo. I. Selective suppression of the development of cell-mediated immunity by soluble alloantigens.
    Bonavida B; Zighelboim J
    Cell Immunol; 1974 Jul; 13(1):52-65. PubMed ID: 4451974
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxicity inhibition studies using 3 M KCl solubilized murine histocompatibility antigens and a new multiple automated sample harvester.
    Ahmed A; Thurman GB; Vannier WE; Sell KW; Strong DM
    J Immunol Methods; 1973 Aug; 3(1):1-16. PubMed ID: 4765855
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxicity inhibition studies using 3 M KC1 solubilized murine histocompatibility antigens and a new multiple automated sample harvester.
    Ahmed A; Thurman GB; Vannier WE; Sell KW; Strong DM
    J Immunol Methods; 1973 Aug; 3(1):1-16. PubMed ID: 4732342
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte-dependent antibody in a tumor xenograft system.
    Simpson E; Beverley PC; Jones V
    Transplant Proc; 1973 Mar; 5(1):161-6. PubMed ID: 4695940
    [No Abstract]   [Full Text] [Related]  

  • 17. Subfragments of the papain solubilized TL antigen.
    Stanton TH; Bennett JC; Wolcott M
    J Immunol; 1975 Oct; 115(4):1013-7. PubMed ID: 1176764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of immune lysis. I. Physiological distinction between target cell death mediated by cytotoxic T lymphocytes and antibody plus complement.
    Russell JH; Masakowski VR; Dobos CB
    J Immunol; 1980 Mar; 124(3):1100-5. PubMed ID: 6965686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization, properties and molecular separation of HL-A alloantigens.
    Mann DL; Rogentine GN; Fahey JL; Nathenson SG
    Transplant Proc; 1969 Mar; 1(1):494-7. PubMed ID: 4109224
    [No Abstract]   [Full Text] [Related]  

  • 20. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.